nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—ABAT—islet of Langerhans—type 2 diabetes mellitus	0.00897	0.0865	CbGeAlD
Vigabatrin—GABBR1—cortex of kidney—type 2 diabetes mellitus	0.00791	0.0764	CbGeAlD
Vigabatrin—ABAT—retina—type 2 diabetes mellitus	0.00766	0.074	CbGeAlD
Vigabatrin—GABBR1—adipose tissue—type 2 diabetes mellitus	0.00732	0.0707	CbGeAlD
Vigabatrin—SLC36A1—nephron tubule—type 2 diabetes mellitus	0.00726	0.0701	CbGeAlD
Vigabatrin—ABAT—nephron tubule—type 2 diabetes mellitus	0.00722	0.0697	CbGeAlD
Vigabatrin—SLC36A1—kidney—type 2 diabetes mellitus	0.00638	0.0616	CbGeAlD
Vigabatrin—ABAT—kidney—type 2 diabetes mellitus	0.00634	0.0612	CbGeAlD
Vigabatrin—SLC36A1—pancreas—type 2 diabetes mellitus	0.00634	0.0612	CbGeAlD
Vigabatrin—ABAT—pancreas—type 2 diabetes mellitus	0.0063	0.0608	CbGeAlD
Vigabatrin—SLC36A1—cortex of kidney—type 2 diabetes mellitus	0.00622	0.06	CbGeAlD
Vigabatrin—ABAT—cortex of kidney—type 2 diabetes mellitus	0.00618	0.0596	CbGeAlD
Vigabatrin—SLC36A1—adipose tissue—type 2 diabetes mellitus	0.00575	0.0555	CbGeAlD
Vigabatrin—ABAT—adipose tissue—type 2 diabetes mellitus	0.00572	0.0552	CbGeAlD
Vigabatrin—SLC36A1—liver—type 2 diabetes mellitus	0.00403	0.0389	CbGeAlD
Vigabatrin—ABAT—liver—type 2 diabetes mellitus	0.00401	0.0387	CbGeAlD
Vigabatrin—GABBR1—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.00135	0.00553	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.00134	0.00547	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.00131	0.00537	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.00129	0.00529	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—GAD2—type 2 diabetes mellitus	0.00123	0.00505	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.00122	0.005	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—MTNR1B—type 2 diabetes mellitus	0.00117	0.00479	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.00116	0.00477	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.00111	0.00457	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.00107	0.0044	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.00107	0.00439	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.00105	0.00432	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.00104	0.00425	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.00103	0.00422	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.00102	0.0042	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00102	0.00417	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00102	0.00417	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.001	0.0041	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—AGTR2—type 2 diabetes mellitus	0.00098	0.00402	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.000979	0.00401	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.000943	0.00386	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000934	0.00383	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.00093	0.00381	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000918	0.00376	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000911	0.00373	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—ADRA2A—type 2 diabetes mellitus	0.000867	0.00356	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000831	0.00341	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000829	0.0034	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000829	0.0034	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000812	0.00333	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.000802	0.00329	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000798	0.00327	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000798	0.00327	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000797	0.00327	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000794	0.00326	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000789	0.00323	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000784	0.00321	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000775	0.00318	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.000774	0.00317	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.000762	0.00312	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000742	0.00304	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000725	0.00297	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.000708	0.0029	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—GNB3—type 2 diabetes mellitus	0.000698	0.00286	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000698	0.00286	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.000692	0.00284	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.00069	0.00283	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00069	0.00283	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—GNB3—type 2 diabetes mellitus	0.000681	0.00279	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.000679	0.00278	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000678	0.00278	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000677	0.00278	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.000658	0.0027	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000656	0.00269	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000655	0.00269	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000628	0.00257	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000622	0.00255	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000611	0.00251	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—ADCY5—type 2 diabetes mellitus	0.000607	0.00249	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.000605	0.00248	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.000605	0.00248	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.000597	0.00245	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—GNB3—type 2 diabetes mellitus	0.000594	0.00243	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.000593	0.00243	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000593	0.00243	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR5—type 2 diabetes mellitus	0.000571	0.00234	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000568	0.00233	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000565	0.00232	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—C3—type 2 diabetes mellitus	0.000558	0.00229	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000557	0.00229	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000553	0.00227	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000552	0.00226	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.00055	0.00225	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.00055	0.00225	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000545	0.00223	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000537	0.0022	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—CALM1—type 2 diabetes mellitus	0.000535	0.00219	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000533	0.00218	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—AGT—type 2 diabetes mellitus	0.00053	0.00217	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000529	0.00217	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000525	0.00215	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000523	0.00214	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000521	0.00213	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000521	0.00213	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000517	0.00212	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000517	0.00212	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000508	0.00208	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000505	0.00207	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000503	0.00206	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000502	0.00206	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000502	0.00206	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000484	0.00198	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000478	0.00196	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—CALM1—type 2 diabetes mellitus	0.000455	0.00186	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000453	0.00186	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000443	0.00181	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000438	0.00179	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000427	0.00175	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000422	0.00173	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000412	0.00169	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000411	0.00169	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.00041	0.00168	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000409	0.00167	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000407	0.00167	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000405	0.00166	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.0004	0.00164	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000397	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.00039	0.0016	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000387	0.00159	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000384	0.00157	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000363	0.00149	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000354	0.00145	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000353	0.00145	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000349	0.00143	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000348	0.00143	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000347	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000346	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000345	0.00142	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000344	0.00141	CbGpPWpGaD
Vigabatrin—Chest pain—Metformin—type 2 diabetes mellitus	0.000342	0.000524	CcSEcCtD
Vigabatrin—Myalgia—Metformin—type 2 diabetes mellitus	0.000342	0.000524	CcSEcCtD
Vigabatrin—Malaise—Irbesartan—type 2 diabetes mellitus	0.000342	0.000524	CcSEcCtD
Vigabatrin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00034	0.000522	CcSEcCtD
Vigabatrin—Headache—Pioglitazone—type 2 diabetes mellitus	0.00034	0.000521	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000339	0.00052	CcSEcCtD
Vigabatrin—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000338	0.000519	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000338	0.000518	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000338	0.00139	CbGpPWpGaD
Vigabatrin—Discomfort—Metformin—type 2 diabetes mellitus	0.000338	0.000517	CcSEcCtD
Vigabatrin—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000338	0.000517	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000337	0.00138	CbGpPWpGaD
Vigabatrin—Nausea—Glipizide—type 2 diabetes mellitus	0.000337	0.000516	CcSEcCtD
Vigabatrin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000336	0.000515	CcSEcCtD
Vigabatrin—Vision blurred—Losartan—type 2 diabetes mellitus	0.000336	0.000515	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000335	0.00137	CbGpPWpGaD
Vigabatrin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000335	0.000514	CcSEcCtD
Vigabatrin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000335	0.000513	CcSEcCtD
Vigabatrin—Pain—Gliclazide—type 2 diabetes mellitus	0.000335	0.000513	CcSEcCtD
Vigabatrin—Tremor—Losartan—type 2 diabetes mellitus	0.000334	0.000512	CcSEcCtD
Vigabatrin—Rash—Glimepiride—type 2 diabetes mellitus	0.000333	0.000511	CcSEcCtD
Vigabatrin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000333	0.00051	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000333	0.00136	CbGpPWpGaD
Vigabatrin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000332	0.000509	CcSEcCtD
Vigabatrin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000332	0.000509	CcSEcCtD
Vigabatrin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000332	0.000509	CcSEcCtD
Vigabatrin—Headache—Glimepiride—type 2 diabetes mellitus	0.000331	0.000508	CcSEcCtD
Vigabatrin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000331	0.000507	CcSEcCtD
Vigabatrin—Cough—Irbesartan—type 2 diabetes mellitus	0.000331	0.000507	CcSEcCtD
Vigabatrin—Headache—Sitagliptin—type 2 diabetes mellitus	0.00033	0.000506	CcSEcCtD
Vigabatrin—Anaemia—Losartan—type 2 diabetes mellitus	0.000329	0.000505	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000328	0.000502	CcSEcCtD
Vigabatrin—Agitation—Losartan—type 2 diabetes mellitus	0.000328	0.000502	CcSEcCtD
Vigabatrin—Oedema—Metformin—type 2 diabetes mellitus	0.000328	0.000502	CcSEcCtD
Vigabatrin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000327	0.000502	CcSEcCtD
Vigabatrin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000326	0.0005	CcSEcCtD
Vigabatrin—Angioedema—Losartan—type 2 diabetes mellitus	0.000326	0.000499	CcSEcCtD
Vigabatrin—Infection—Metformin—type 2 diabetes mellitus	0.000325	0.000499	CcSEcCtD
Vigabatrin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000325	0.000499	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000325	0.00133	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000325	0.00133	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000324	0.000496	CcSEcCtD
Vigabatrin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000323	0.000495	CcSEcCtD
Vigabatrin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000323	0.000495	CcSEcCtD
Vigabatrin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000322	0.000494	CcSEcCtD
Vigabatrin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000322	0.000494	CcSEcCtD
Vigabatrin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000322	0.000494	CcSEcCtD
Vigabatrin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000321	0.000493	CcSEcCtD
Vigabatrin—Malaise—Losartan—type 2 diabetes mellitus	0.000321	0.000493	CcSEcCtD
Vigabatrin—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000321	0.000493	CcSEcCtD
Vigabatrin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000321	0.000492	CcSEcCtD
Vigabatrin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000321	0.000492	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000321	0.00132	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000321	0.00132	CbGpPWpGaD
Vigabatrin—Vertigo—Losartan—type 2 diabetes mellitus	0.00032	0.000491	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00032	0.000491	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00032	0.000491	CcSEcCtD
Vigabatrin—Somnolence—Valsartan—type 2 diabetes mellitus	0.00032	0.00049	CcSEcCtD
Vigabatrin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000319	0.000489	CcSEcCtD
Vigabatrin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000319	0.000488	CcSEcCtD
Vigabatrin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000318	0.000488	CcSEcCtD
Vigabatrin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000317	0.000485	CcSEcCtD
Vigabatrin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000315	0.000483	CcSEcCtD
Vigabatrin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000314	0.000481	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000314	0.00129	CbGpPWpGaD
Vigabatrin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000313	0.00048	CcSEcCtD
Vigabatrin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000313	0.00048	CcSEcCtD
Vigabatrin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000313	0.000479	CcSEcCtD
Vigabatrin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000313	0.000479	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000312	0.00128	CbGpPWpGaD
Vigabatrin—Cough—Losartan—type 2 diabetes mellitus	0.000311	0.000477	CcSEcCtD
Vigabatrin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000311	0.000477	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000311	0.00127	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000311	0.000476	CcSEcCtD
Vigabatrin—Fatigue—Valsartan—type 2 diabetes mellitus	0.00031	0.000475	CcSEcCtD
Vigabatrin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000309	0.000474	CcSEcCtD
Vigabatrin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000309	0.000474	CcSEcCtD
Vigabatrin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000309	0.000474	CcSEcCtD
Vigabatrin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000309	0.000474	CcSEcCtD
Vigabatrin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000308	0.000473	CcSEcCtD
Vigabatrin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000308	0.000471	CcSEcCtD
Vigabatrin—Constipation—Valsartan—type 2 diabetes mellitus	0.000308	0.000471	CcSEcCtD
Vigabatrin—Infection—Irbesartan—type 2 diabetes mellitus	0.000307	0.000471	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000307	0.00047	CcSEcCtD
Vigabatrin—Fatigue—Orlistat—type 2 diabetes mellitus	0.000306	0.00047	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000306	0.00126	CbGpPWpGaD
Vigabatrin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000306	0.000468	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000305	0.00125	CbGpPWpGaD
Vigabatrin—Pain—Orlistat—type 2 diabetes mellitus	0.000304	0.000466	CcSEcCtD
Vigabatrin—Chest pain—Losartan—type 2 diabetes mellitus	0.000303	0.000465	CcSEcCtD
Vigabatrin—Myalgia—Losartan—type 2 diabetes mellitus	0.000303	0.000465	CcSEcCtD
Vigabatrin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000303	0.000465	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000303	0.00124	CbGpPWpGaD
Vigabatrin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000303	0.000465	CcSEcCtD
Vigabatrin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000303	0.000465	CcSEcCtD
Vigabatrin—Anxiety—Losartan—type 2 diabetes mellitus	0.000302	0.000464	CcSEcCtD
Vigabatrin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000301	0.000461	CcSEcCtD
Vigabatrin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0003	0.000461	CcSEcCtD
Vigabatrin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.0003	0.00046	CcSEcCtD
Vigabatrin—Tension—Ramipril—type 2 diabetes mellitus	0.0003	0.00046	CcSEcCtD
Vigabatrin—Discomfort—Losartan—type 2 diabetes mellitus	0.0003	0.00046	CcSEcCtD
Vigabatrin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000299	0.000458	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000298	0.000457	CcSEcCtD
Vigabatrin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000298	0.000457	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000297	0.00122	CbGpPWpGaD
Vigabatrin—Nervousness—Ramipril—type 2 diabetes mellitus	0.000297	0.000455	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000297	0.00122	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000296	0.00121	CbGpPWpGaD
Vigabatrin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000294	0.000451	CcSEcCtD
Vigabatrin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000294	0.000451	CcSEcCtD
Vigabatrin—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000294	0.00045	CcSEcCtD
Vigabatrin—Confusional state—Losartan—type 2 diabetes mellitus	0.000293	0.00045	CcSEcCtD
Vigabatrin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000293	0.000449	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000292	0.0012	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000292	0.0012	CbGpPWpGaD
Vigabatrin—Somnolence—Metformin—type 2 diabetes mellitus	0.000291	0.000446	CcSEcCtD
Vigabatrin—Oedema—Losartan—type 2 diabetes mellitus	0.000291	0.000446	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000291	0.000445	CcSEcCtD
Vigabatrin—Infection—Losartan—type 2 diabetes mellitus	0.000289	0.000443	CcSEcCtD
Vigabatrin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000288	0.000442	CcSEcCtD
Vigabatrin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000288	0.000442	CcSEcCtD
Vigabatrin—Tremor—Ramipril—type 2 diabetes mellitus	0.000286	0.000439	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000286	0.00117	CbGpPWpGaD
Vigabatrin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000286	0.000438	CcSEcCtD
Vigabatrin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000285	0.000437	CcSEcCtD
Vigabatrin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000285	0.000436	CcSEcCtD
Vigabatrin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000284	0.000436	CcSEcCtD
Vigabatrin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000284	0.000435	CcSEcCtD
Vigabatrin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000283	0.000434	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000283	0.00116	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000283	0.000433	CcSEcCtD
Vigabatrin—Fatigue—Metformin—type 2 diabetes mellitus	0.000282	0.000433	CcSEcCtD
Vigabatrin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000282	0.000433	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000282	0.000432	CcSEcCtD
Vigabatrin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000281	0.000431	CcSEcCtD
Vigabatrin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000281	0.000431	CcSEcCtD
Vigabatrin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000281	0.000431	CcSEcCtD
Vigabatrin—Agitation—Ramipril—type 2 diabetes mellitus	0.000281	0.000431	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000281	0.00115	CbGpPWpGaD
Vigabatrin—Constipation—Metformin—type 2 diabetes mellitus	0.00028	0.000429	CcSEcCtD
Vigabatrin—Angioedema—Ramipril—type 2 diabetes mellitus	0.000279	0.000428	CcSEcCtD
Vigabatrin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000278	0.000425	CcSEcCtD
Vigabatrin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000277	0.000425	CcSEcCtD
Vigabatrin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000277	0.000425	CcSEcCtD
Vigabatrin—Malaise—Ramipril—type 2 diabetes mellitus	0.000276	0.000422	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000275	0.00113	CbGpPWpGaD
Vigabatrin—Rash—Glyburide—type 2 diabetes mellitus	0.000275	0.000421	CcSEcCtD
Vigabatrin—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000275	0.000421	CcSEcCtD
Vigabatrin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000275	0.000421	CcSEcCtD
Vigabatrin—Vertigo—Ramipril—type 2 diabetes mellitus	0.000275	0.000421	CcSEcCtD
Vigabatrin—Headache—Glyburide—type 2 diabetes mellitus	0.000273	0.000419	CcSEcCtD
Vigabatrin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000272	0.000417	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000272	0.00111	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.00027	0.00111	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00027	0.000414	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.00027	0.0011	CbGpPWpGaD
Vigabatrin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000269	0.000412	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000268	0.0011	CbGpPWpGaD
Vigabatrin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000268	0.000411	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000268	0.000411	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000267	0.000409	CcSEcCtD
Vigabatrin—Cough—Ramipril—type 2 diabetes mellitus	0.000267	0.000409	CcSEcCtD
Vigabatrin—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000267	0.000409	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000266	0.00109	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000265	0.00109	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000265	0.000406	CcSEcCtD
Vigabatrin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000265	0.000406	CcSEcCtD
Vigabatrin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000265	0.000406	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000264	0.00108	CbGpPWpGaD
Vigabatrin—Pain—Irbesartan—type 2 diabetes mellitus	0.000264	0.000405	CcSEcCtD
Vigabatrin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000264	0.000405	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000263	0.00108	CbGpPWpGaD
Vigabatrin—Insomnia—Losartan—type 2 diabetes mellitus	0.000263	0.000403	CcSEcCtD
Vigabatrin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000262	0.000401	CcSEcCtD
Vigabatrin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000261	0.0004	CcSEcCtD
Vigabatrin—Urticaria—Metformin—type 2 diabetes mellitus	0.00026	0.000399	CcSEcCtD
Vigabatrin—Chest pain—Ramipril—type 2 diabetes mellitus	0.00026	0.000399	CcSEcCtD
Vigabatrin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00026	0.000399	CcSEcCtD
Vigabatrin—Myalgia—Ramipril—type 2 diabetes mellitus	0.00026	0.000399	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.00026	0.00106	CbGpPWpGaD
Vigabatrin—Anxiety—Ramipril—type 2 diabetes mellitus	0.000259	0.000397	CcSEcCtD
Vigabatrin—Nausea—Glyburide—type 2 diabetes mellitus	0.000259	0.000397	CcSEcCtD
Vigabatrin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000259	0.000397	CcSEcCtD
Vigabatrin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000259	0.000397	CcSEcCtD
Vigabatrin—Somnolence—Losartan—type 2 diabetes mellitus	0.000259	0.000396	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000258	0.000396	CcSEcCtD
Vigabatrin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000258	0.000396	CcSEcCtD
Vigabatrin—Discomfort—Ramipril—type 2 diabetes mellitus	0.000257	0.000394	CcSEcCtD
Vigabatrin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000256	0.000393	CcSEcCtD
Vigabatrin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000255	0.000391	CcSEcCtD
Vigabatrin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000255	0.00039	CcSEcCtD
Vigabatrin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000254	0.00039	CcSEcCtD
Vigabatrin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000253	0.000388	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000253	0.000387	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000252	0.00103	CbGpPWpGaD
Vigabatrin—Confusional state—Ramipril—type 2 diabetes mellitus	0.000252	0.000386	CcSEcCtD
Vigabatrin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000251	0.000385	CcSEcCtD
Vigabatrin—Fatigue—Losartan—type 2 diabetes mellitus	0.000251	0.000384	CcSEcCtD
Vigabatrin—Oedema—Ramipril—type 2 diabetes mellitus	0.000249	0.000382	CcSEcCtD
Vigabatrin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000249	0.000382	CcSEcCtD
Vigabatrin—Constipation—Losartan—type 2 diabetes mellitus	0.000249	0.000381	CcSEcCtD
Vigabatrin—Pain—Losartan—type 2 diabetes mellitus	0.000249	0.000381	CcSEcCtD
Vigabatrin—Rash—Gliclazide—type 2 diabetes mellitus	0.000247	0.000378	CcSEcCtD
Vigabatrin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000247	0.000378	CcSEcCtD
Vigabatrin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000246	0.000377	CcSEcCtD
Vigabatrin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000246	0.000376	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000245	0.00101	CbGpPWpGaD
Vigabatrin—Headache—Gliclazide—type 2 diabetes mellitus	0.000245	0.000376	CcSEcCtD
Vigabatrin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000245	0.000375	CcSEcCtD
Vigabatrin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000244	0.000375	CcSEcCtD
Vigabatrin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000244	0.000375	CcSEcCtD
Vigabatrin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000243	0.000373	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000243	0.000996	CbGpPWpGaD
Vigabatrin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000242	0.000371	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000241	0.00099	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00024	0.000367	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000238	0.000365	CcSEcCtD
Vigabatrin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000238	0.000365	CcSEcCtD
Vigabatrin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000235	0.00036	CcSEcCtD
Vigabatrin—Asthenia—Metformin—type 2 diabetes mellitus	0.000235	0.00036	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000235	0.000962	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000233	0.000955	CbGpPWpGaD
Vigabatrin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000233	0.000356	CcSEcCtD
Vigabatrin—Pruritus—Metformin—type 2 diabetes mellitus	0.000232	0.000355	CcSEcCtD
Vigabatrin—Urticaria—Losartan—type 2 diabetes mellitus	0.000231	0.000354	CcSEcCtD
Vigabatrin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00023	0.000352	CcSEcCtD
Vigabatrin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00023	0.000352	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.00023	0.000942	CbGpPWpGaD
Vigabatrin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000229	0.000351	CcSEcCtD
Vigabatrin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000228	0.000349	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000227	0.000348	CcSEcCtD
Vigabatrin—Rash—Valsartan—type 2 diabetes mellitus	0.000227	0.000348	CcSEcCtD
Vigabatrin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000227	0.000347	CcSEcCtD
Vigabatrin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000226	0.000346	CcSEcCtD
Vigabatrin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000226	0.000346	CcSEcCtD
Vigabatrin—Headache—Valsartan—type 2 diabetes mellitus	0.000225	0.000345	CcSEcCtD
Vigabatrin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000224	0.000344	CcSEcCtD
Vigabatrin—Rash—Orlistat—type 2 diabetes mellitus	0.000224	0.000344	CcSEcCtD
Vigabatrin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000224	0.000343	CcSEcCtD
Vigabatrin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000224	0.000343	CcSEcCtD
Vigabatrin—Headache—Orlistat—type 2 diabetes mellitus	0.000223	0.000341	CcSEcCtD
Vigabatrin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000222	0.00034	CcSEcCtD
Vigabatrin—Somnolence—Ramipril—type 2 diabetes mellitus	0.000222	0.00034	CcSEcCtD
Vigabatrin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.00022	0.000337	CcSEcCtD
Vigabatrin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000219	0.000335	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000219	0.000896	CbGpPWpGaD
Vigabatrin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000217	0.000332	CcSEcCtD
Vigabatrin—Dizziness—Metformin—type 2 diabetes mellitus	0.000217	0.000332	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000217	0.000888	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000215	0.00033	CcSEcCtD
Vigabatrin—Fatigue—Ramipril—type 2 diabetes mellitus	0.000215	0.00033	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000215	0.00088	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000215	0.00088	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000214	0.000329	CcSEcCtD
Vigabatrin—Nausea—Valsartan—type 2 diabetes mellitus	0.000214	0.000327	CcSEcCtD
Vigabatrin—Constipation—Ramipril—type 2 diabetes mellitus	0.000213	0.000327	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000212	0.000867	CbGpPWpGaD
Vigabatrin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000212	0.000324	CcSEcCtD
Vigabatrin—Nausea—Orlistat—type 2 diabetes mellitus	0.000211	0.000324	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000209	0.000857	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000209	0.000857	CbGpPWpGaD
Vigabatrin—Asthenia—Losartan—type 2 diabetes mellitus	0.000209	0.00032	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000209	0.000855	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000209	0.000855	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000209	0.000855	CbGpPWpGaD
Vigabatrin—Vomiting—Metformin—type 2 diabetes mellitus	0.000208	0.000319	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000208	0.000851	CbGpPWpGaD
Vigabatrin—Rash—Metformin—type 2 diabetes mellitus	0.000207	0.000317	CcSEcCtD
Vigabatrin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000206	0.000316	CcSEcCtD
Vigabatrin—Pruritus—Losartan—type 2 diabetes mellitus	0.000206	0.000315	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000206	0.000844	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000206	0.000315	CcSEcCtD
Vigabatrin—Headache—Metformin—type 2 diabetes mellitus	0.000205	0.000315	CcSEcCtD
Vigabatrin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000204	0.000313	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000204	0.000313	CcSEcCtD
Vigabatrin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000199	0.000305	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000199	0.000814	CbGpPWpGaD
Vigabatrin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000198	0.000304	CcSEcCtD
Vigabatrin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000197	0.000302	CcSEcCtD
Vigabatrin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000197	0.000302	CcSEcCtD
Vigabatrin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000197	0.000301	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000195	0.000801	CbGpPWpGaD
Vigabatrin—Rash—Irbesartan—type 2 diabetes mellitus	0.000195	0.000299	CcSEcCtD
Vigabatrin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000195	0.000298	CcSEcCtD
Vigabatrin—Nausea—Metformin—type 2 diabetes mellitus	0.000195	0.000298	CcSEcCtD
Vigabatrin—Headache—Irbesartan—type 2 diabetes mellitus	0.000194	0.000297	CcSEcCtD
Vigabatrin—Dizziness—Losartan—type 2 diabetes mellitus	0.000192	0.000295	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000191	0.000783	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000189	0.000773	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000186	0.000764	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000185	0.00076	CbGpPWpGaD
Vigabatrin—Vomiting—Losartan—type 2 diabetes mellitus	0.000185	0.000284	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000184	0.000755	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000184	0.000282	CcSEcCtD
Vigabatrin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000184	0.000281	CcSEcCtD
Vigabatrin—Rash—Losartan—type 2 diabetes mellitus	0.000183	0.000281	CcSEcCtD
Vigabatrin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000183	0.000281	CcSEcCtD
Vigabatrin—Headache—Losartan—type 2 diabetes mellitus	0.000182	0.000279	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000181	0.000744	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000181	0.000742	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000181	0.000741	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.00018	0.000737	CbGpPWpGaD
Vigabatrin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000179	0.000274	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000177	0.000727	CbGpPWpGaD
Vigabatrin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000176	0.000271	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000173	0.000711	CbGpPWpGaD
Vigabatrin—Nausea—Losartan—type 2 diabetes mellitus	0.000173	0.000265	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000172	0.000706	CbGpPWpGaD
Vigabatrin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000171	0.000262	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000168	0.000687	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000167	0.000685	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000167	0.000685	CbGpPWpGaD
Vigabatrin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000165	0.000253	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000165	0.000675	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000163	0.000667	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000162	0.000664	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000162	0.000664	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000159	0.000653	CbGpPWpGaD
Vigabatrin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000159	0.000243	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000159	0.00065	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000159	0.00065	CbGpPWpGaD
Vigabatrin—Rash—Ramipril—type 2 diabetes mellitus	0.000157	0.000241	CcSEcCtD
Vigabatrin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000157	0.000241	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000157	0.000642	CbGpPWpGaD
Vigabatrin—Headache—Ramipril—type 2 diabetes mellitus	0.000156	0.00024	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000152	0.000624	CbGpPWpGaD
Vigabatrin—Nausea—Ramipril—type 2 diabetes mellitus	0.000148	0.000227	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000147	0.000605	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000147	0.000602	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000145	0.000594	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000145	0.000594	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000143	0.000585	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000142	0.000583	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000136	0.000556	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000133	0.000546	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000133	0.000546	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000126	0.000517	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000125	0.000512	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000123	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000123	0.000505	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000123	0.000503	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000122	0.000501	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000121	0.000496	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000119	0.000488	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000119	0.000486	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000117	0.000481	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000114	0.000466	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000111	0.000457	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000107	0.000438	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000105	0.00043	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—C3—type 2 diabetes mellitus	0.000102	0.00042	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.77e-05	0.0004	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.75e-05	0.000399	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGT—type 2 diabetes mellitus	9.73e-05	0.000399	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.57e-05	0.000392	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—type 2 diabetes mellitus	9.54e-05	0.000391	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—LEP—type 2 diabetes mellitus	9.54e-05	0.000391	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.43e-05	0.000386	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.99e-05	0.000369	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.51e-05	0.000349	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—INS—type 2 diabetes mellitus	8.15e-05	0.000334	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.02e-05	0.000329	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.88e-05	0.000323	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.88e-05	0.000323	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.84e-05	0.000321	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.48e-05	0.000307	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.15e-05	0.000293	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.15e-05	0.000293	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.73e-05	0.000276	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.12e-05	0.000251	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.07e-05	0.000249	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.03e-05	0.000247	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.73e-05	0.000235	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.67e-05	0.000232	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.56e-05	0.000228	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.29e-05	0.000217	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.15e-05	0.000211	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.72e-05	0.000194	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.63e-05	0.00019	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.56e-05	0.000146	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.28e-05	0.000135	CbGpPWpGaD
